
Suprit Gupta
20 posts

Suprit Gupta
@SupritGupta25
Senior Scientist, Immuno-Oncology @EikonTherapeutics












New Resource online now at Dev Cell: Oncogene-regulated release of extracellular vesicles - zpr.io/R2uJN



Our latest paper out today in @NatureCellBio and previously on @biorxivpreprint 👇 Congrats to lead author @SupritGupta25 and team. Excited to continue exploring the many roles of #lysosomes in #pancreaticcancer nature.com/articles/s4155… 1/

Our latest paper out today in @NatureCellBio and previously on @biorxivpreprint 👇 Congrats to lead author @SupritGupta25 and team. Excited to continue exploring the many roles of #lysosomes in #pancreaticcancer nature.com/articles/s4155… 1/

Our latest paper out today in @NatureCellBio and previously on @biorxivpreprint 👇 Congrats to lead author @SupritGupta25 and team. Excited to continue exploring the many roles of #lysosomes in #pancreaticcancer nature.com/articles/s4155… 1/

Welcoming the new year with a new preprint identifying a cancer specific mechanism for lysosomal membrane stabilization. "Lysosomal retargeting of Myoferlin mitigates membrane stress to enable pancreatic cancer growth". Thread below. 👇1/ biorxiv.org/content/10.110…









Damon Runyon-Rachleff Innovator Rushika M. Perera, PhD, and colleagues may have the answer as to why pancreatic cancers are resistant to immunotherapies. bit.ly/3dO1Oa9 @rushika_perera @ucsf

